Gilead Sciences (GILD) Q2 Earnings and Revenues Beat Estimates

Gilead Sciences (GILD) came out with quarterly earnings of $2.01 per share, beating the Zacks Consensus Estimate of$ 1.61 per share. This compares to earnings of $1.34 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 24.84%. A quarter ago, it was expected that this HIV and hepatitis C drugmaker would post a loss of$ 1.49 per share when it actually produced a loss of $1.32, delivering a surprise of 11.41%.Over the last four quar ...